0001209191-17-053350.txt : 20170919
0001209191-17-053350.hdr.sgml : 20170919
20170919175938
ACCESSION NUMBER: 0001209191-17-053350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170915
FILED AS OF DATE: 20170919
DATE AS OF CHANGE: 20170919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nagler David
CENTRAL INDEX KEY: 0001416175
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37833
FILM NUMBER: 171092876
MAIL ADDRESS:
STREET 1: ARYX THERAPEUTICS,INC.
STREET 2: 6300 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Audentes Therapeutics, Inc.
CENTRAL INDEX KEY: 0001628738
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461606174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 415-638-6556
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-15
0
0001628738
Audentes Therapeutics, Inc.
BOLD
0001416175
Nagler David
C/O AUDENTES THERAPEUTICS, INC.
600 CALIFORNIA STREET, 17TH FLOOR
SAN FRANCISCO
CA
94108
0
1
0
0
SVP, HR & Corp. Affairs
Common Stock
2017-09-15
4
M
0
3750
2.1852
A
3750
D
Common Stock
2017-09-15
4
S
0
3750
25.00
D
0
D
Stock Option (right to buy)
2.1852
2017-09-15
4
M
0
3750
0.00
D
2025-02-04
Common Stock
3750
41097
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The option vested as to 25% of the total shares on February 1, 2016, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on February 1, 2019, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Thomas Soloway as attorney-in-fact for David Nagler
2017-09-19